BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 21779498)

  • 1. The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.
    Neel NF; Martin TD; Stratford JK; Zand TP; Reiner DJ; Der CJ
    Genes Cancer; 2011 Mar; 2(3):275-87. PubMed ID: 21779498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.
    Gentry LR; Martin TD; Reiner DJ; Der CJ
    Biochim Biophys Acta; 2014 Dec; 1843(12):2976-2988. PubMed ID: 25219551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
    Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
    Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
    Yan C; Theodorescu D
    Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
    Cooper JM; Bodemann BO; White MA
    Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallel Rap1>RalGEF>Ral and Ras signals sculpt the C. elegans nervous system.
    Mardick JI; Rasmussen NR; Wightman B; Reiner DJ
    Dev Biol; 2021 Sep; 477():37-48. PubMed ID: 33991533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.
    Peyssonnaux C; Provot S; Felder-Schmittbuhl MP; Calothy G; Eychène A
    Mol Cell Biol; 2000 Oct; 20(19):7068-79. PubMed ID: 10982823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and involvement of Ral GTPases in colorectal cancer.
    Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
    Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and pharmacologic dissection of Ras effector utilization in oncogenesis.
    Campbell PM; Singh A; Williams FJ; Frantz K; Ulkü AS; Kelley GG; Der CJ
    Methods Enzymol; 2006; 407():195-217. PubMed ID: 16757325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.
    Goi T; Rusanescu G; Urano T; Feig LA
    Mol Cell Biol; 1999 Mar; 19(3):1731-41. PubMed ID: 10022860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras effector switching as a developmental strategy.
    Reiner DJ
    Small GTPases; 2011 Mar; 2(2):109-112. PubMed ID: 21776412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
    Yin J; Pollock C; Tracy K; Chock M; Martin P; Oberst M; Kelly K
    Mol Cell Biol; 2007 Nov; 27(21):7538-50. PubMed ID: 17709381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
    Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
    J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
    Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
    J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ral Signals through a MAP4 Kinase-p38 MAP Kinase Cascade in C. elegans Cell Fate Patterning.
    Shin H; Kaplan REW; Duong T; Fakieh R; Reiner DJ
    Cell Rep; 2018 Sep; 24(10):2669-2681.e5. PubMed ID: 30184501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.
    Castro AF; Campos T; Babcock JT; Armijo ME; Martínez-Conde A; Pincheira R; Quilliam LA
    J Cell Biochem; 2012 Apr; 113(4):1253-64. PubMed ID: 22121046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdependent action of RalGEF and Erk in Ras-induced primitive endoderm differentiation of F9 embryonal carcinoma cells.
    Verheijen MH; Wolthuis RM; Defize LH; den Hertog J; Bos JL
    Oncogene; 1999 Aug; 18(31):4435-9. PubMed ID: 10442634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.